Increased Twist expression has been linked to advanced disease stages and poorer overall survival in osteosarcoma patients, suggesting that targeting Twist may provide therapeutic opportunities to reverse EMT and enhance sensitivity to chemotherapy [90,99]. This evidence concerns the gene TWIST1 and osteosarcoma.